Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface
- PMID: 16540230
- DOI: 10.1016/j.biochi.2006.02.004
Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface
Abstract
In most cases, anti-protein aptamers are selected by systematic evolution of ligands by exponential enrichment (SELEX) using purified recombinant protein targets. Cell surface proteins, however, are not easy targets for SELEX due to the difficulties associated with their purification. Here, we developed a novel SELEX procedure (referred to as TECS-SELEX) in which cell-surface displayed recombinant protein is directly used as the selection target. Using this method, we isolated RNA aptamers against transforming growth factor-beta type III receptor expressed on Chinese hamster ovary (CHO) cells. One of the RNA aptamers has a dissociation constant in the 1 nM range and competed with transforming growth factor-beta to bind to the cell surface receptor in vitro.
Similar articles
-
A novel method to generate aptamers against recombinant targets displayed on the cell surface.Nucleic Acids Symp Ser (Oxf). 2005;(49):351-2. doi: 10.1093/nass/49.1.351. Nucleic Acids Symp Ser (Oxf). 2005. PMID: 17150778
-
Complex target SELEX.Acc Chem Res. 2008 Jan;41(1):130-8. doi: 10.1021/ar700142z. Acc Chem Res. 2008. PMID: 18193823 Review.
-
Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers.RNA. 2007 Apr;13(4):614-22. doi: 10.1261/rna.334307. Epub 2007 Feb 5. RNA. 2007. PMID: 17283213 Free PMC article.
-
Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method.Biotechnol Lett. 2008 May;30(5):829-34. doi: 10.1007/s10529-007-9629-6. Epub 2008 Jan 4. Biotechnol Lett. 2008. PMID: 18175068
-
Disease-specific biomarker discovery by aptamers.Cytometry A. 2009 Sep;75(9):727-33. doi: 10.1002/cyto.a.20766. Cytometry A. 2009. PMID: 19565638 Review.
Cited by
-
RNA aptamer evolution: two decades of SELEction.Int J Mol Sci. 2011;12(12):9155-71. doi: 10.3390/ijms12129155. Epub 2011 Dec 8. Int J Mol Sci. 2011. PMID: 22272125 Free PMC article. Review.
-
Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis.BMC Infect Dis. 2012 Apr 20;12:96. doi: 10.1186/1471-2334-12-96. BMC Infect Dis. 2012. PMID: 22520654 Free PMC article.
-
Generating aptamers by cell-SELEX for applications in molecular medicine.Int J Mol Sci. 2012;13(3):3341-3353. doi: 10.3390/ijms13033341. Epub 2012 Mar 12. Int J Mol Sci. 2012. PMID: 22489154 Free PMC article. Review.
-
New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization.Mol Ther Nucleic Acids. 2014 Aug 5;3(8):e183. doi: 10.1038/mtna.2014.34. Mol Ther Nucleic Acids. 2014. PMID: 25093707 Free PMC article.
-
Aptamers: An Emerging Tool for Diagnosis and Therapeutics in Tuberculosis.Front Cell Infect Microbiol. 2021 Jul 1;11:656421. doi: 10.3389/fcimb.2021.656421. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34277465 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources